Simplex Trading
XGN icon

Simplex Trading’s Exagen XGN Stock Holding History

Simplex Trading’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$63.3K Sell
21,100
-10,700
-34% -$41.4K ﹤0.01% 5604
2025
Q4 		$193K Buy
31,800
+10,000
+46% +$91K ﹤0.01% 4271
2025
Q3 		$239K Buy
21,800
+16,700
+327% +$148K ﹤0.01% 4723
2025
Q2 		$35K Buy
5,100
+3,300
+183% +$20.1K ﹤0.01% 6279
2025
Q1 		$6K Buy
+1,800
New +$6.79K ﹤0.01% 7500
2022
Q4 		– Sell
-1,900
Closed -$5K – 10605
2022
Q3 		$5K Sell
1,900
-1,000
-34% -$5.58K ﹤0.01% 8831
2022
Q2 		$16K Buy
2,900
+2,000
+222% +$11.6K ﹤0.01% 7848
2022
Q1 		$7K Buy
+900
New +$7.76K ﹤0.01% 9219

Other funds holding XGN

Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return

Simplex Trading's XGN Position: Q1 2025 in Review

Simplex Trading sold out of Exagen (XGN) in Q1 2025, closing a stake of 81 shares — an estimated $306 sold.

Simplex Trading first reported a position in XGN in Q4 2021 and held it in 6 quarters. The position peaked at $1K in Q3 2024. 38 funds tracked by Wall St. Rank hold XGN as of Q1 2025.

  • Simplex Trading reported no remaining Exagen position as of Q1 2025 after selling out during the quarter.
  • Simplex Trading sold 81 Exagen shares in Q1 2025, an estimated $306.
  • Simplex Trading first reported a position in Exagen in Q4 2021 and held it in 6 quarters.
  • Simplex Trading's Exagen position peaked at $1K in Q3 2024.
  • 38 funds tracked by Wall St. Rank held Exagen as of Q1 2025.

Based on Simplex Trading's 13F filing for Q1 2025, filed 12 May 2025.